HDAC7 and neurodegenerative disease: Thus, therapies designed to induce astrocyte lysosomal clearance in disease pathogenesis via manipulation of HDAC7 or its downstream target ac-K310 on TFEB may be advantageous for preventing AD and other neurodegenerative diseases.